Literature DB >> 21410405

STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoter.

Constance Zugowski1, Franziska Lieder, Annekatrin Müller, Josephine Gasch, Florian M Corvinus, Richard Moriggl, Karlheinz Friedrich.   

Abstract

Aberrant activation of STAT3 in colorectal carcinoma (CRC) tissue is correlated with elevated expression of matrix metalloproteinase-1 (MMP-1). We analyzed transcriptional regulation of the human MMP-1 promoter in CRC cells by tyrosine phosphorylated (pY-) STAT3. One of six putative STAT binding elements within a 4.3 kb MMP-1 trancriptional promoter fragment showed a particular high affinity for STAT3 in vitro. However, the most profound regulatory influence on MMP-1 promoter activity resides in a proximal region relative to the transcriptional start, bearing a pair of putative binding sites for STAT3 and AP-1. Mutational analysis of the combined STAT3/AP-1 recognition element revealed that the integrity of the STAT3 binding site is necessary, but not sufficient for both DNA interaction and transcriptional regulation by activated STAT3. Instead, the adjacent AP-1 site was essential for pY-STAT3-mediated transcription on the MMP-1 promoter. DNA-protein binding assays provided strong evidence for complex formation of STAT3 and c-Jun governed by protein-protein contacts. We observed striking coincidence for concerted aberrant activation of both STAT3 and AP-1 in human colon cancer specimens. This finding supports the notion that the combination of inappropriate STAT3 and AP-1 activities drives elevated MMP-1 expression and tissue invasion in colorectal cancer and is of clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21410405     DOI: 10.1515/BC.2011.038

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  22 in total

Review 1.  Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.

Authors:  Jessica Felton; Shien Hu; Jean-Pierre Raufman
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

2.  STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo.

Authors:  Melanie Spitzner; Birte Roesler; Christian Bielfeld; Georg Emons; Jochen Gaedcke; Hendrik A Wolff; Margret Rave-Fränk; Frank Kramer; Tim Beissbarth; Julia Kitz; Jürgen Wienands; B Michael Ghadimi; Reinhard Ebner; Thomas Ried; Marian Grade
Journal:  Int J Cancer       Date:  2013-09-03       Impact factor: 7.396

3.  Lung Adenocarcinomas and Lung Cancer Cell Lines Show Association of MMP-1 Expression With STAT3 Activation.

Authors:  Alexander Schütz; Katrin Röser; Jana Klitzsch; Franziska Lieder; Fritz Aberger; Wolfgang Gruber; Kristina M Mueller; Alexander Pupyshev; Richard Moriggl; Karlheinz Friedrich
Journal:  Transl Oncol       Date:  2015-04       Impact factor: 4.243

4.  Propolis augments apoptosis induced by butyrate via targeting cell survival pathways.

Authors:  Eric Drago; Michael Bordonaro; Seon Lee; Wafa Atamna; Darina L Lazarova
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

5.  Increased growth of colorectal liver metastasis following partial hepatectomy.

Authors:  P Krause; H Flikweert; M Monin; A Seif Amir Hosseini; G Helms; G Cantanhede; B M Ghadimi; S Koenig
Journal:  Clin Exp Metastasis       Date:  2013-02-06       Impact factor: 5.150

6.  Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma.

Authors:  C Gordziel; J Bratsch; R Moriggl; T Knösel; K Friedrich
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

7.  Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.

Authors:  María C Díaz Flaqué; Natalia M Galigniana; Wendy Béguelin; Rocío Vicario; Cecilia J Proietti; Rosalía Russo; Martín A Rivas; Mercedes Tkach; Pablo Guzmán; Juan C Roa; Esteban Maronna; Viviana Pineda; Sergio Muñoz; María Mercogliano; Eduardo H Charreau; Patricio Yankilevich; Roxana Schillaci; Patricia V Elizalde
Journal:  Breast Cancer Res       Date:  2013-12-17       Impact factor: 6.466

Review 8.  PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franziska Briest; Patricia Grabowski
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556

9.  SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells.

Authors:  Sylvia Müller; Yuan Chen; Torsten Ginter; Claudia Schäfer; Marc Buchwald; Lienhard M Schmitz; Jana Klitzsch; Alexander Schütz; Andrea Haitel; Katharina Schmid; Richard Moriggl; Lukas Kenner; Karlheinz Friedrich; Claude Haan; Iver Petersen; Thorsten Heinzel; Oliver H Krämer
Journal:  Oncotarget       Date:  2014-05-30

10.  STAT3 Target Genes Relevant to Human Cancers.

Authors:  Richard L Carpenter; Hui-Wen Lo
Journal:  Cancers (Basel)       Date:  2014-04-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.